Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs

Potential Targeting of Renal Fibrosis in Diabetic Kidney Disease Using MicroRNAs

Diabetic kidney disease (DKD) is a major health problem and one of the leading causes of end-stage renal disease worldwide. Despite recent advances, there exists an urgent need for the development of new treatments for DKD. DKD is characterized by the excessive synthesis and deposition of extracellu...

Full description

Bibliographic Details
Main Authors: Hiroko Sakuma, Shinji Hagiwara, Phillip Kantharidis, Tomohito Gohda, Yusuke Suzuki
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
diabetic kidney disease
microRNA
renal fibrosis
end-stage renal disease
antifibrosis treatment
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.587689/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.587689/full

Similar Items